Search results
Emcure Pharmaceuticals IPO: Issue booked 4.98 times on the second bidding day. Check latest GMP,...
Livemint· 1 hour agoEmcure Pharmaceuticals IPO subscription status: Emcure Pharmaceuticals, backed by Bain Capital,...
Emcure Pharmaceuticals IPO booked nearly 3x so far on Day 2. Check GMP and other details - The...
The Economic Times· 3 hours agoAhead of the issue opening, the company raised Rs 582 crore from anchor investors. Marquee investors...
Aramco, ADNOC reportedly weighing bids for Australia's Santos, analysts sceptical
VCCircle· 8 hours agoSaudi Aramco and Abu Dhabi National Oil Company (ADNOC) have been separately considering bids for...
YouTuber earns Rs 3 cr in 2 months running gold smuggling racket at Chennai airport, arrested
The Economic Times· 23 hours agoA souvenir shop at Chennai airport has been revealed as a front for a Sri Lankan gold smuggling...
Mastercard and LuLu Group forge multimarket partnership
Electronic Payments· 3 hours agoBeing piloted for the first time, LuLu will also deploy the Mastercard Next Gen Point of...
Ilia Topuria Gives Update on His Return UFC Fight Against Max Holloway; Details Inside
Pinkvilla· 17 hours agoUndefeated UFC featherweight contender Ilia Topuria managed to capture the UFC featherweight...
Max Holloway Calls Out Ilia Topuria for Lying About Title Fight Stall Accusation: ‘Guy Is Making up...
Pinkvilla· 7 hours agoMax Holloway is not happy with Ilia Topuria. The UFC featherweight champion and the reigning UFC BMF...
UFC 304, UFC 305 dates, main events, live streaming: Will there be fight night this weekend? - The...
The Economic Times· 12 hours agoUFC 304 and UFC 305 are set to be the most awaited events after the conclusion UFC 303. UFC Fight...
Reliance Industries Invests Rs 4,330 cr in Retail Unit in FY24
The Economic Times· 18 hours agoReliance Industries infused Rs 4,330 crore into its flagship retail company Reliance Retail in the...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 7 hours agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...